Literature DB >> 21849228

Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study.

Thulasi Thirugnanasambathan1, Carmel M Hawley, Sunil V Badve, Stephen P McDonald, Fiona G Brown, Neil Boudville, Kathryn J Wiggins, Kym M Bannister, Philip Clayton, David W Johnson.   

Abstract

BACKGROUND: Determinants and outcomes of peritoneal dialysis (PD)-associated peritonitis occurring within 4 weeks of completion of therapy of a prior episode caused by the same (relapse) or different organism (recurrence) recently have been characterized. However, determinants and outcomes of peritonitis occurring more than 4 weeks after treatment of a prior episode caused by the same (repeated) or different organism (nonrepeated) are poorly understood. STUDY
DESIGN: Observational cohort study using Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) data. SETTING & PARTICIPANTS: All Australian PD patients between October 1, 2003, and December 31, 2007, with first episodes of repeated or nonrepeated peritonitis. PREDICTORS: Repeated versus nonrepeated peritonitis, according to International Society of PD (ISPD) criteria. OUTCOMES & MEASUREMENTS: Relapse, hospitalization, catheter removal, hemodialysis transfer, and death.
RESULTS: After a peritonitis episode, the probability that a subsequent episode represented repeated rather than nonrepeated peritonitis was highest in the second month (41%), then progressively decreased to a stable level of 14% from 6 months onward. When first episodes of repeated (n = 245) or nonrepeated peritonitis (n = 824) were analyzed, repeated peritonitis was predicted independently by a shorter elapsed time from the prior episode (adjusted OR per day elapsed, 0.91; 95% CI, 0.88-0.94). Staphylococcus aureus and coagulase-negative staphylococcus were isolated more frequently in repeated peritonitis, whereas Gram-negative, streptococcal, and fungal organisms were recovered more frequently in nonrepeated peritonitis. Using multivariate logistic regression, repeated peritonitis was associated independently with higher relapse (OR, 5.41; 95% CI, 3.72-7.89) and lower hospitalization rates (OR, 0.63; 95% CI, 0.46-0.85), but catheter removal, hemodialysis transfer, and death rates similar to nonrepeated peritonitis. LIMITATIONS: Limited covariate adjustment. Residual confounding and coding bias could not be excluded.
CONCLUSIONS: Repeated and nonrepeated peritonitis episodes are caused by different spectra of micro-organisms and have different outcomes. Study findings suggest that the ISPD definition for repeated peritonitis should be limited to 6 months. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21849228     DOI: 10.1053/j.ajkd.2011.06.018

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis.

Authors:  Wen Tang; Yeoungjee Cho; Carmel M Hawley; Sunil V Badve; David W Johnson
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

Review 2.  Continuous Quality Improvement Initiatives to Sustainably Reduce Peritoneal Dialysis-Related Infections in Australia and New Zealand.

Authors:  Melissa Nataatmadja; Yeoungjee Cho; David W Johnson
Journal:  Perit Dial Int       Date:  2016-09-10       Impact factor: 1.756

Review 3.  Difficult peritonitis cases in children undergoing chronic peritoneal dialysis: relapsing, repeat, recurrent and zoonotic episodes.

Authors:  Sevcan A Bakkaloglu; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2014-09-18       Impact factor: 3.714

4.  The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis.

Authors:  Sarah Stevenson; Wen Tang; Yeoungjee Cho; David W Mudge; Carmel M Hawley; Sunil V Badve; David W Johnson
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

5.  Intraperitoneal Antibiotic Utilization among Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with Peritonitis at a Tertiary Hospital Setting in Malaysia.

Authors:  Mastura Ahmad; Che Suraya Zin; Ab Fatah Ab Rahman
Journal:  J Pharm Bioallied Sci       Date:  2020-11-05

6.  Longer antibiotic durations for treating peritoneal dialysis-associated peritonitis: helpful or harmful?

Authors:  Htay Htay; Yeoungjee Cho; David W Johnson
Journal:  Clin Kidney J       Date:  2021-01-11

Review 7.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

8.  Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study.

Authors:  Xiaoyan Ma; Yingfeng Shi; Min Tao; Xiaolu Jiang; Yi Wang; Xiujuan Zang; Lu Fang; Wei Jiang; Lin Du; Dewei Jin; Shougang Zhuang; Na Liu
Journal:  BMJ Open       Date:  2020-02-13       Impact factor: 2.692

9.  Is combined peritoneal dialysis and hemodialysis redundant? A nationwide study from Taiwan.

Authors:  Mu-Chi Chung; Tung-Min Yu; Ming-Ju Wu; Ya-Wen Chuang; Chih-Hsin Muo; Cheng-Hsu Chen; Chao-Hsiang Chang; Jeng-Jer Shieh; Peir-Haur Hung; Jein-Wen Chen; Chi-Jung Chung
Journal:  BMC Nephrol       Date:  2020-08-15       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.